Rifaat Safadi - Info zur Person mit Bilder, News & Links

	Düsseldorf

	Hadassah Israel COVID-19 Jerusalem Liver Unit Hadassah Medical Hadassah University Hospital Medical Center Professor

News

(1 - 4 von 6

–alle anzeigen

)

BioLineRx Announces In-licensing of Liver Fibrosis Project Under...

pipelinereview.com

BioLineRx Announces In-licensing of Liver Fibrosis Project Under Strategic Collaboration

History of Changes for Study: NCT

clinicaltrials.gov

Contact:Contact: Gaby Rohe Contact:Principal Investigator: Rifaat Safadi, Dr.

Vacunación COVID-19 en pacientes con enfermedad hepáticaasscat-hepatitis.org › eventos › webinar-easl-vacunacio...

asscat-hepatitis.org

Mar 9, · Verena Keitel, Hospital Universitario de Düsseldorf, Alemania Rifaat Safadi, Hadassah Medical Centers of the Hebrew, Universidad de ...

Chemomab Announces Late-Breaking Presentation of CM-101 First...

www.prnewswire.com

· Presented by: Rifaat Safadi, Head of Liver unit, Hadassah medical center, Israel. In the Liver Meeting Digital Experience™ Chemomab ...

Netzwerk-Profile

(1 - 4 von 6

–alle anzeigen

)

Facebook: Rifaat Safadi | Facebookwww.facebook.com › rifaat.safadi

Facebook: Prof. Rifaat Safadi - Home | Facebookwww.facebook.com › ... › Doctor › Gastroenterologist

LinkedIn: Prof. Rifaat Safadi - Professor - Hadassa Medical centers the hebrew ...

Rifaat Safadi's profile on LinkedIn, the world's largest professional community. Prof. Rifaat has 1 job listed on their profile. See the complete profile on LinkedIn ...

LinkedIn: Rifaat Safadi - Professor - Hadassah University Medical Center ...il.linkedin.com › rifaat-safadi-a62bb4155

Prof. Rifaat Safadi M.D.. Rifaat-Professor in Medicine, Faculty of Medicine, Hadassah University Hospital, Jerusalem & a visiting Scholar, at the division of Liver ...Es fehlt: ASTA GmbH" Prof. Rifaat Safadi M.D.. Rifaat-Professor in Medicine, Faculty of Medicine, Hadassah University Hospital, Jerusalem & a visiting Scholar, at the division of Liver ... Es fehlt: ASTA GmbH"

Interessen

COVID-19 Vaccinations May Be Weakened by Liver Disease

www.medscape.com

A researcher recommends testing people with liver disease for antibodies after vaccinating them with the Pfizer vaccine against COVID-19, with the possibility...

Can-Fite Reports Third Quarter Financial Results & Provides...

www.businesswire.com

Can-Fite Reports Third Quarter Financial Results & Provides Clinical Update

Table of contents | Gut

gut.bmj.com

Rifaat Safadi. Modelling a dream: the molecular prevention of pancreatic cancer (28 April, 2010). Ernest Hawk, Sherri Patterson.

Bücher

Non-Alcoholic Fatty Liver Disease Research Google Books

books.google.de

This book is a printed edition of the Special Issue "Non-Alcoholic Fatty Liver Disease Research 2016" that was published in IJMS

Dokumente zum Namen

Heat Shock Protein 90 Promotes RNA Helicase DDX5 Accumulation and...

papers.ssrn.com

· Rifaat Safadi. Hebrew University of Jerusalem - Hadassah Medical Center ... Rifaat Safadi. Hebrew University of Jerusalem - Hadassah Medical ...

Rifaat Safadi - Academia.edu

independent.academia.edu

Academia.edu is a place to share and follow research.

Can-Fite BioPharma (CANF) Namodenoson Abstract Selected as âBest of...

www.streetinsider.com

· The study's Principal Investigator Dr. Rifaat Safadi made the oral presentation titled “A Phase 2, Randomized, Double-Blind, ...

Wissenschaftliche Veröffentlichungen

DFG - GEPRIS - Dr. Rifaat Safadi

gepris.dfg.de

Dr. Rifaat Safadi, Liver and Gastroenterology Units, P. O. Box , Jerusalem, Israel

Artikel & Meinungen

Google Groups: medicine ff information

Universitatsklinik der Ruhr-Universitat Bochum Bad Y Rifaat Safadi Dr. Liver Unit, Division Hadassah University

Tumeric- Elixir of Life

tumericalive-blog.tumblr.com

Rifaat Safadi. Gut 2010;59: Complementary and herbal agents such as curcumin are returning from the past to enter the future of medicine.

Sonstiges

Dr Rifaat Safadi Archives - Israël Science Infowww.israelscienceinfo.com › mot-clef › dr-rifaat-saf...

www.israelscienceinfo.com

Dr. Rifaat Safadi, head of the Hadassah Medical Organization's Liver Unit, in its Institute of Gastroenterology and Liver Diseases, is collaborating with ...

Dr. Rifaat Safadi Archives | Hadassah Magazine

www.hadassahmagazine.org

Immune modulation of the liver, a field that rapidly went global, was born in the early 2000s, when Dr. Rifaat Safadi, an Arab-Israeli gastroenterologist ...

Dr. Rifaat Safadi | Hadassah International

hadassahinternational.org

Dr. Rifaat Safadi, director of the Liver Unit at Hadassah Hospital Ein Kerem, has found that his patients who received liver transplants and those with ...

Can-Fite Reports Positive Top Line Results from its Phase ...

pipelinereview.com

Apr 07, · Prof. Rifaat Safadi commented, “We are very pleased with the outcome of this study which shows clear efficacy and safety. One of the goals of this study was to determine the optimal dosage, and we have achieved that, as it appears from the data that 25 mg is both safe and most effective. Namodenoson is a very strong candidate for continued ...

Occult Advanced Fibrosis in the General Populationlivertree.easl.eu › easl › international.liver.congress › rifaat.safadi.occult.ad...

livertree.easl.eu

Safadi R ; ; SAT-029 Topic: Fibrosis/Cirrhosis. Assoc. Prof. Rifaat Safadi Contributions. VIEW ePOSTER. DOWNLOAD POSTER DOCUMENT.

Verwandte Suchanfragen zu Rifaat Safadi

Personen
Vorname "Rifaat" (9)
Name "Safadi" (59)

sortiert nach Relevanz / Datum

Erweiterte Suche

Dossier exportieren

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z